This Week
  • Williamson businesses and residents are signing up to become part of a solar system.

  • RIT, RGH hold opening ceremonies for RIT's Clinical Health Sciences Center.

  • Thomas Bonadio has grown the Bonadio Group into the nation's 40th largest CPA firm.

  • Steve General Contractor was founded in 1973 by a Jamaican immigrant.

  • Tim Dougherty found satisfaction in creating a nutritional lifestyle.

  • The 2015 edition features an exclusive interview with Paychex CEO Martin Mucci.

B&L parent acquires PreCision Dermatology

Rochester Business Journal
July 8, 2014

Valeant Pharmaceuticals International Inc. has completed an acquisition of PreCision Dermatology Inc., officials said Tuesday.

Valeant, the Quebec-based parent of Bausch & Lomb Inc., announced in February an agreement to acquire PreCision, based in Cumberland, R.I., in a $475 million cash deal, Terms included an agreement for Valeant to pay an additional $25 million if PreCision met certain sales goals.

PreCision Dermatology products include the skin-care drugs Locoid, Hylatopic and Clindagel.

Valeant acquired Bausch & Lomb last year, moving the eye-care company’s headquarters from Rochester to Valeant’s U.S. base in New Jersey.

Valeant last month launched a hostile bid to take over of the Botox maker Allergan Inc.

Allergan has yet to comment on Valeant’s June tender offer of $72 cash plus .83 Valeant shares for each Allergan share. The offer expires Aug. 15 but could be extended, Valeant officials said last month.

In a May 27 investor conference, Allergan executives scoffed at a Valeant proposal to offer $48 share plus .83 Valeant shares as woefully undervaluing the Botox maker.

Calling Valeant a serial acquirer interested mainly in short-term gains, the Allergan officials in May accused the Quebec company of painting an overly rosy picture of Bausch & Lomb’s first-quarter market gains and overstating its tax advantages.

Valeant shares (NYSE: VRX) on Tuesday were trading at $121.13, down $2.16 or 1.75 percent from Monday’s close.   
(c) 2014 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail

What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment


Not registered? Sign up now!

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google